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1023-101 Pred ic t ive  Ab i l i ty  o f  Co lo r  M-Mode and Doppler Tissue 
Imaging Compared  to Trad i t iona l  Measures  o f  D iasto l ic  
Dysfunction in Ch i ld ren  
Adel K. Younoszai. Mario Garcia, Daniel Murphy, The Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Backaround: There is no reliable echocardiographic method of evaluating diastolic func- 
tion in children. Two new modalities, Color M-mode (CMM) and Doppler tissue imaging 
(DTI), are used in adults. We evaluated their ability to identify patients with abnormal car- 
diac function and compared them to traditional methods. 
Methods: Measurements were made in two groups: 1) Normal - referred to rule out dis- 
ease with a normal echocardiogram [ n = 27 (14 male), mean age = 8.1yr (range: 0.05 - 
17)], and 2) Cardiomyopathy - diagnosis of dilated, hypertrophic or restrictive cardiomy- 
opathy In = 22 (14 male), mean age = 13.9 yr (range: 1.6 - 19.6)]. Echocardiogrephic 
measurements included: mitral E and A waves, deceleration time, pulmonary vein S, D, 
and A reversal waves, isovolumic relaxation time, CMM derived propagation velocity (Vp) 
of the mitral inflow, and DTI derived early diastolic velocity (Era) of the four margins of the 
mitral annulus. Receiver operating characteristic analysis was performed on all measure- 
ments. 
Results: 
Measure Area under curve Standard error 
E wave 0.685 0,076 
A wave 0.591 0.082 
Deceleration time 0.328 0.079 
S wave 0.476 0,084 
D wave 0.658 0.079 
A reversal wave 0.307 0.079 
IVRT 0.507 0.090 
Vp 0.826 0.061 
Em septal 0.924 0.039 
Em anterior 0.895 0,046 
Em lateral 0.891 0.047 
Em posterior 0.878 0.050 
Conclusions: All Em measurements and Vp have very strong predictive abilities, Other 
measures have mild-to-no predictive ability to separate healthy from abnormal patients. 
Both CMM and DTI are promising adjuncts to traditional echocardiogrephic methods of 
evaluating diastolic function. Future studies should include establishment of age- 
adjusted normal data and correlation with clinical and hemodynamic measure of cardiac 
dysfunction. 
1023-102 Digital  3-D Ve loc i ty  Reconstructions Allow Ext rac t ion  o f  
the Vena Cont rac ts  (VC) Area fo r  F low Rate 
Computation: An In V i t ro  S tudy  Using Raw Scan l ine  
T rans fer  and Reconstruction of 3-D Data 
Yoshiki Mort, Paul R. Detmer, Xiang-Ning Li, Roy W. Martin, Antoinette Kenny, Susan L. 
Martin, David J. Sahn, Oregon Health & Science Universi~ Portland, Oregon, ATL 
Ultrasound, Bothell, Washington. 
Methods: Our study imaged proximal jet flows from 3 orifices (rectangular, circular and 
triangular, each 0.24 cm =) with an ATL 3000 using a 5MHz multiplane probe with stepper 
function controlled by the scanner and a connection allowing transfer of raw scanUne dig- 
ital velocity data to an SGI workstation. By interrogating jet flow in the in vitro model 
(stroke volumes 10-60 cc/beat measured by an ultrasonic flowmeter) parallel to the direc- 
tion of propagation and analyzing it in a cross-section selected for smallest diameter and 
flattest velocity profile, a high velocity core in the VC region could be identified. Results: 
After rotational acquisition at 5 ° spacing, 3D digital color VC regions extracted and mea- 
sured as cress-sectional areas matched the fluid dynamically determined effective orifice 
area (EOA) for the modeled valve defects (p = NS, mean difference + 0.06 crn~). Also, 
when VC area was integrated with the CW Doppler velocity time integral, a high correla- 
tion with beth actual peak instantaneous flow rate 3.7-11.4 L/rain (r = 0.98)(slight overes- 
timation) and stroke volume/beet (r = 0.98) was obtained. VC areas had extreme 
similarity to the orifices' shapes. Conclusions: The ability to analyze cross-sectional dig- 
ital velocity data from proximal jet flow fields from 3D datasets obtained parallel to flow 
enhances measurement of VC as a reflection of EOA. 
i l 
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1047-97 Ef fect  of Vssodilator Therapy on Left  A t r lovent r l cu la r  
Va lve Regurg i ta t ion  Af ter  A t r iovent r i cu la r  Septa l  Defect  
Repai r  
Reenu S. Eacen, Claudio Ramaciotti, Matthew S. Lemler, Daniel Stromberg, University 
of Texas, Southwestern Medical Center, Dallas, Texas. 
Background: Postoperative left atrioventricular valve (LAVV) regurgitation after atrioven- 
tricular septal defect (AVSD) repair is a significant risk factor for morbidity and mortality, 
We performed a prospective study to determine whether vasodilator therapy with Nitro- 
prusslde changes the severity of LAVV regurgitation after AVSD repair. 
Methods: Postoperative patients received a Nitroprusslde infusion at 0.5mcg/kg/min, 
fitreted to a maximum dose of 2mcg/kg/min in an attempt to decrease systolic blood 
pressure by 15%. The vena contracta of the LAVV regurgitant jet, and regurgitant fraction 
across the LAW were measured before and during Nitroprusside administration by tran- 
sthoracic echocardiogrephy. All measurements were made off line in blinded fashion. 
Cardiac output and systemic vascular resistance (SVR) were evaluated during the study 
periods using arterial and venous blood gases. 
Results: Of the 17 patients studied, 6 patients achieved both a decrease in systolic blood 
pressure and a significant reduction of SVR (> 10%) during Nitroprusside infusion. These 
patients had a significant increase in their cardiac output (15.6%, p=0.002), decrease in 
the vena contracta of the regurgitant jet in the apical four chamber view (29.5%, p=0.03) 
and a decrease in the LAVV regurgitant fraction (35,9%, p=0.025). Those patients who 
did not demonstrate a decrease in SVR, whether or not accompanied by a decrease in 
blood pressure (via decreased stroke volume, n=5), did not experience a reduction in 
LAVV regurgitation. 
Conclusions: 1, Vasodilator administration which diminishes SVR augments cardiac out- 
put and decreases LAVV regurgitation after AVSD repair. 2. Vasodilation that solely 
achieves a reduction in blood pressure without an accompanying decrease in SVR does 
not reduce LAVV regurgitation in postoperative AVSD patients. 
1047-98 Carved i lo l  fo r  the  Treatment  o f  Congest ive  Heart  Fa i lure 
in Ch i ld ren  With Csrdlomyopathy 
Paolo Rusconi. Esmail Redha, Jennifer R. Marin, Maria Rossique-Gonzalez, Ming-Lon 
Young, Grace S. Wolff, University of Miami School of Medicine, Miami, Florida, Jackson 
Memorial Hospital, Miami, Florida. 
Background: Carvedilol (CAR) has proven to be effective in the treatment of congestive 
heart failure (CHF) in adults. However there is paucity of data on the use of beta-block- 
ers, their safety and efficacy in the treatment of CHF in children. Our goal is to assess 
safety and efficacy of CAR in the treatment of CHF in children. 
Methods: Retrospective analysis of clinical data of 22 children with cardiomyopathy 
(CMP) and CHF who received CAR after conventional treatment with Digoxin, Angio- 
tensin Converting Enzyme Inhibitor and diuretics. Change in clinical status before and 
after CAR treatment was assessed using New York Heart Association (NYHA) class. 
Echocerdiogrem was performed before starting CAR and at 3-6 months interval to moni- 
tor ejection fraction (EF) and spbencity index (ratio between left ventricle transverse 
diameter and left ventricle longitudinal diameter in diastole and multiplied by 100). CAR 
was started (mean initial dose=0.1 mg/Kg/day in two divided doses), at a median of 10.6 
months after the diagnosis of CMP was made. CAR was increased weekly to an average 
maximum dose of 0.8 mg/Kg/day (0.25-1.2). 
Results: There were 13 males, median age: 8.9 years (0.5-18). CMP etiology: idiopathic 
11, myocardifis 5, muscular dystrophy 3, others 3. NYHA classification was >~2 in all 
patients; 8 children ware in class 4. All patients had EF .~=40%. In 2 patients CAR was 
stopped after 1 week because of worsening CHF in one and asthma in the other. Mean 
follow up was 19.5 months (2.7-37). Four patients died 1 awaiting transplant and 3 with 
muscular dystrophy. Three patients underwent heart transplant. One child developed first 
and Mobitz I second degree atrioventricular block, EF improved from 27+7% before CAR 
was started to 39~12% (mean improvement 12.5%, p< 0.001), The average sphericity 
index decreased from 85t-9% to 79:t:11% (mean change 9.4%, p<0,005). NYHA class 
improved from 3.15 to 1,95 (p<0.001). 
Conclusion: When used in combination with standard therapy CAR is well tolerated and 
seems to improve clinical status and cardiac function of children with CHF. Control stud- 
ies with a larger number of patients are required to determine if CAR improves mortality 
and reduce hospitalization in this age group. 
1047-99 A Medical  S t rategy to Address  Pers i s tent  Chest  Tube 
Dra inage Af ter  the Fontan  Operat ion  
Joseah R. Cava. Raymond T. Fedderly, Sarah M. Bevandic, Michelle Steitzer, Patrick J. 
Phelan, Kan N. Hor, James S. Tweddell, S. Bert Litwin, Medical College of Wisconsin, 
Milwaukee, Wisconsin, Children's Hospital of Wisconsin, Milwaukee, Wisconsin. 
Background: Surgical modifications have dramatically improved survival following the 
Fontan operation; however, morbidity related to persistent pleural effusion continues to 
be a significant problem. Total parenteral nutrition (TPN) along with eliminating feedings 
(NPO) and pleurel sclerosis have been used to treat persistent drainage. Risk factors for 
persistent pleural drainage have been previously reported, although medical manage- 
ment in this population of patients varies widely, A standardized medical management 
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scheme is proposed to decrease persistent pleural effusions after the Fontan operation. 
Methods: From August 2000 to July 2001, 20 patients who underwent an uncomplicated 
fenestrated Fontan procedure were placed on a standardized medical regimen (Group 
1). The regimen consisted of aggressive diuresis utilizing IV furosemide and enteral 
aldactazide, 80% fluid restriction, aftedoad reduction, supplemental oxygen, and low fat 
diet. A group of patients who underwent uncomplicated fenestrated Fontan prior to 
August 2000 (n=20) was used as a control (Group 2). Patient demographics between 
groups were similar except for surgical approach. Extracardiac Fontans were performed 
in 90% and 45% of Groups 1 and 2 respectively. Previously our group has shown no sta- 
tistically significant difference in pleural effusions between extrecardiac and intracardiac 
approaches. One-way ANOVA was done to evaluate length of hospital stay and duration 
of pleural chest tube placement. Fisher's exact 2-sided test was done for the use of an 
NPO/TPN strategy and the use of pleural sclerosis. 
Results: The standardized medical regimen was well tolerated. The mean length of stay 
was 9 vs. 15 days for Groups 1 and 2 respectively, p-value <0.01. Pleural chest tubes 
remained in place for 6 vs. 11 days for Groups 1 and 2 respectively, p-value <0.05. Five 
patients in Group 2 were made NPO and placed on TPN; four had pleurodesis. Neither 
treatment was necessary for any patient in Group 1. 
Conclusions: Initial results suggest that the standardized medical regimen shortened 
hospitalization and decreased morbidity following the Fontan operation. 
1047-100 The Overdiagnosis of Marfan Syndrome: Results From 
a Large Pediatr ic  and Adult Cardiovascular Connective 
T issue  Disorders  Cl in ic 
Elizabeth A. Sharks, Curt J. Daniels, Ohio State Universi~ Columbus, Ohio, Children's 
Hospital, Columbus, Ohio. 
Background: Marfan syndrome (MFS) is a connective tissue disorder with significant car- 
diovascular risk for aortic dilation, aneurysm and dissection. Making the correct diagnosis 
(dx) of MFS carries significant cardiovascular advantages by decreasing morbidity and 
mortality. Assigning this dx in patients (pts) who do not meet diagnostic criteria (over-dx), 
has significant psychological effects, leads to unnecessary cardiovascular follow-up and 
testing, influences insurability, and significantly alters lifestyle. This study was performed 
to evaluate whether pts previously diagnosed with MFS were accurately diagnosed and 
to evaluate the factors that lead to over-dx. Methods: Over the past 12 months, 213 pts 
(127 male; 86 female) referred to our cardiovascular connective tissue disorders clinic 
were prospectively evaluated for MFS; age ranged 1 to 62 years. Detailed family history, 
and clinical criteria-anthropometric measurements, dilated eye exams, radiologic studies, 
and aortic root measurements (echocardiography) using normal values standardized for 
age and body surface area, were used to support the dx of MFS. Results: 44 pts, age 
range 1 to 42 years (30 male; 14 female) met diagnostic criteria for MFS. Previous MFS 
dx was confirmed in 24 pts; 19 pts were newly diagnosed; and 1 pt previously without 
MFS dx.had dural ectasia on MRI, fulfilling MFS dx criteria. 13/37 pts (35%) with previous 
MFS dx did not meet sufficient diagnostic criteria: 4 of the 13 had a first-degree relative 
with MFS and 9 were over-dx based on skeletal features alone.The MFS dx was 
removed in the over-dx group. Conclusion: Failure to correctly assign MFS dx as well as 
over-dx of MFS can lead to significant life-long detrimental consequences. In our study 
35 % of patients with previous dx of MFS did not meet cdteria and were over-dx. The cor- 
rect dx of MFS relies on a combination of family history data plus methodical clinical eval- 
uation of ocular, skeletal, cardiovascular, and neurologic systems and should be 
performed in an experienced center. 
1047-101 Aort ic  Regurg i tat ion in an Out let  Ventr icu lar  Septal  
Defect  Complicated by Right Coronary Cusp Prolapse: 
Predictors of Prognosis 
Hideshi Tomita, Yoshio Arakaki, Ken-ichi Kurosaki, Toshikatsu Yagihara, Shigeyuki 
Echigo, National Cardiovascular Center, Osaka, Japan, Kurashiki Central Hospital, 
Kurashiki, Japan. 
Background 
Early surgery to prevent progressive aortic regurgitation (AR) is commonly recom- 
mended for an out]at ventricular septal defect (o-VSD) complicated by right coronary 
cusp prolapse (RCCP). However AR usually progresses slowly or remains mild for a long 
time after the right coronary cusp first prolapses. 
Methods 
Among 525 patients with an o-VSD who underwent he Doppler echocardiography (echo) 
from January 1985 to May 2001, we reviewed the echo of the aortic valve and associated 
AR in139 patients. Patients in groups 1-3 did not undergo surgery beyond 18 years old. 
Group 1 consists of 26 patients without any deformity of the aortic cusp. Group 2 includes 
56 patients who did not have AR despite typical RCCP. In 38 patients with RCCP and 
AR, AR was not progressive and subclinical (Group 3). Nineteen patients underwent sur- 
gical treatment because of moderate to severe AR (Group 4). The right coronary cusp 
deformity index [RCCD=(the length of the deformed right coronary cusp/the diameter of 
the aortic valve ring)] and the right cusp imbalance index [R/L = (width of right coronary 
cusp/width of left coronary cusp)) were compared among the 4 groups. 
Results 
The type of o-VSD (subarterial vs. outlet muscular) in groups 1-4 was; 15 vs. 11,22 vs. 
34, 25 vs. 13, and 18 vs. 1 (p<0.01). RCCP was firstly detected at significantly younger 
age in group 4 (6+5 years) than in group 2 (15+8) and 3 (14+5, p<0.01). In group 4, AR 
was first diagnosed at 17+19 years, that was earlier than in group 3 where AR was first 
detected at 26+17 years (p<O.01). Both RCCD (0.40i-0.20) and R/L (1.39~0.04) in group 
4 were larger than those in groups 2 (0.31_+0.09, 1.15i-0.10) and 3 (0.26~0.09, 
1.13:L-0.07, p<0.01). 
Conclusion 
JACC March 6, 2002 
Subarterial VSD, early occurrence of RCCP with AR, large RCCD and R/L were predic- 
tors of progressive serious AR, However, AR remains mild and not progressive beyond 
18 years in the considerable number of patients. 
1047-102 Delayed D iagnos is  of  Kawassk l  Disease in the Gamma 
Globulin Era: How Often and Why? Are the Criteria Too 
Str ict?  
Umakumaran Ponniah. Frank C. Smith, Nader H. Atallah-Yunes, Rae-EIlen W. Kavey, 
Craig J. Byrum, Daniel A. Kveselis, Winston E. Gaum, SUNY-Upstate Medical University 
Syracuse, New York. 
Since gamma globulin therapy (IVGG) is most effective during the first 10 days of illness 
in reducing the risk of coronary artery aneurysms (CAA) in children with Kawasaki Dis- 
ease (KD) we retrospectively reviewed all cases of KD from 1978-2001 to determine the 
following: 1 ) Is KD diagnosed late (>10 clays after onset of illness) as often in the IVGG 
era (defined as after 8/87) as in the pre-IVGG era (before 8/87)? 2) Are pts diagnosed 
more often with < 5 criteria in the IVGG era than pre-IVGG and do they have CAA more 
often than those with 35 criteria? 3) Is the late diagnosis of KD due to poor detection of 
KD by physicians in pts with 3 5 criteria or due to delayed appearance of criteria? Com- 
plete data were available in 217/285 pts. The mean time to diagnosis (Dx) was evaluated 
in pts with definite KD (those with 35 criteria or with < 5 criteria and CAA, n=173). Number 
of pts with < 5 vs pts with 3 5 criteria was determined in 217 pts. Results: Mean time to Dx 
was shorter in the IVGG era than in the pre-IVGG era (7.7d±4.3 vs 10.2d±7.9; p=.0135), 
but 33% of pts pre-IVGG and 22% in the IVGG group were diagnosed late (p=NS). Num- 
ber of pts with <5 criteria was not significantly different between the groups (23% in IVGG 
group versus 24% pre-IVGG; p=NS). Incidence of CAA was similar in pts with <5 criteda 
(13.7%) and pts with 3 5 criteria (10.2%; p=NS). Of the 30 pts in the IVGG era diagnosed 
late, 13(43%) developed the 5th criterion late (peeling), 5(17%) had <5 criteria with CAA 
(atypical KD),and 12(40%) were diagnosed late with 3 5 criteria. CAA were seen in 23% 
of pts in the late diagnosis group. Conclusion: Although KD is diagnosed sooner in the 
IVGG era, the number of cases diagnosed after 10 days remains high. 40% of late cases 
were diagnosed late in spite of fulfilling 3 5 criteria; however, the other 60% were delayed 
either because the 5th criterion (peeling) did not appear until after 10 days of illness or 
because suspicion of KD in spite of < 5 criteria led to the echo diagnosis of CAA. These 
data emphasize the need for a high index of suspicion of KD in children with <5 criteria 
and for continued education about the importance of prompt Dx. The results suggest that 
strict adheranca to current criteria prevents the timely diagnosis of KD in a significant 
number of cases, 
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1072-97 Should We Use 2-D Echo to Assess RV Form and 
Function in Adu l ts  With Repaired Tetralogy of  Fal lot? 
Candice Silversides, Gruschen R. Veldtman. Gary D. Webb, Judith Therrien, Claudia 
Quammie, Dare-May Rowlins, Naeem Merchant, Annette Flyrme, Min-Jin Jung, Samuel 
Siu, Brian W. McCrindle, University of Toronto Congenital Cardiac Centre for Adults, 
Toronto, Ontario, Canada. 
Background. 2-D echo assessment of RV form & function may be inaccurate because of 
the non-geometric shape of the RV. Methods. We prospectively recruited & evaluated 65 
consecutive patients >18 years with standardized clinical assessment, 2-D echo, & MRI. 
One observer graded the RV visually as follows (echo): 1= normal function or enddias- 
tolic volume (EDV), 2 = mild dysfunction or enlargement, 3 = moderate dysfunction or 
enlargement; 4 = severe dysfunction or enlargement. Echo was compared with MRI. 
Results. Median age was 31 years (range 18 to 63). 35 (54%) were female. 25 (39%) 
patients had transannular patch repair. Conclusions. Echo assessment of the RV gives 
important initial information, but may be inaccurate. Different echo grades of RVEF & 
RVEDV frequently overlap when compared to MRI quantification. 
Table 2. RVEF assessment 
RVEF echo Number with MRI-RVEF for each echo MRI range of RVEF for 
grading both tests grade, Mean ±SD each echo grade, % 
1 17 45±8 28-56 
2 25 39±10 12-51 
3 11 31±11 17-45 
Table 1. RVEDV assessment 
RVEDV echo Numberwith MRI-RVEDV for each echo MRI RVEDV range for 
grading both tests grade, Mean±SD (mls) each echo grade (mls) 
1 7 134±64 50-270 
2 19 174±58 50-285 
3 19 211±63 77-354 
4 7 228±81 t t 4-360 
